ERFO Share Price Performance
€1.70
0.68 (65.85%)
Price €1.70
Share Price€1.70
Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable
Aug 29
Laboratorio Farmaceutico Erfo S.p.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ERFO Community Narratives
There are no narratives available yet.
Recent ERFO News & Updates
Is There Now An Opportunity In Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)?
Aug 19Laboratorio Farmaceutico Erfo (BIT:ERFO) Might Be Having Difficulty Using Its Capital Effectively
Jul 02Laboratorio Farmaceutico Erfo S.p.A.'s (BIT:ERFO) P/E Still Appears To Be Reasonable
May 22Is It Too Late To Consider Buying Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)?
Feb 20Laboratorio Farmaceutico Erfo S.p.A. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.044
- Gross Margin
- 39.95%
- Net Profit Margin
- 4.73%
- Debt/Equity Ratio
- 18.0%
Laboratorio Farmaceutico Erfo S.p.A. Competitors
Snowflake Analysis
About ERFO
- Founded
- 2013
- Employees
- 47
- CEO
- WebsiteView website
Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. The company was founded in 2013 and is based in Villafranca Tirrena, Italy.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Italian Market Performance
- 7 Days: 1.2%
- 3 Months: 5.9%
- 1 Year: 26.4%
- Year to Date: 23.2%
Over the last 7 days, the market has risen 1.2%, driven by gains of 4.8% in the Consumer Discretionary sector. The market is up 26% over the last 12 months. As for the next few years, earnings are expected to grow by 9.9% per annum. Market details ›